Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 186 (RN7SKP186) is a noncoding RNA pseudogene, homologous to the functional 7SK small nuclear RNA gene; it does not have protein-coding potential, is not known to be expressed, and there is no evidence for any functional, therapeutic, or biomarker role. It is one of many RN7SK-related pseudogenes in the human genome. The functional, canonical 7SK snRNA regulates transcription elongation by acting as a scaffold within the 7SK ribonucleoprotein complex, but this biological role is limited to the true RN7SK gene, not its pseudogenes[1][3][5]. There are no known drugs, safety concerns, or disease associations related to RN7SKP186. The use of RN7SKP186 as a therapeutic or diagnostic target is unwarranted because it is a pseudogene and not functionally expressed in cells[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 186 (RN7SKP186).